Biomarkers of Diabetes

Biomarkers are molecular markers used as direct or indirect markers of the extent of a disease. HbA1c is considered as the biomarker in diabetes for assessing the risk factor related to retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored.

  • Novel Biomarkers
  • Advances in Molecular Diagnostics
  • HbA1c Biomarker

Related Conference of Biomarkers of Diabetes

March 25-26, 2024

5th Annual Conference on Diabetes

London, UK
July 11-12, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Biomarkers of Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in